English
简体中文
Total: £ 56.28
Published Date: 2025-09-15 | Pages: 151 | Tables: 153 | Pharma & Healthcare
The global market for Avian Influenza Vaccines was estimated to be worth US$ 1100 million in 2024 and is forecast to a readjusted size of US$ 1592 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
This report aims to provide a comprehensive presentation of the global market for Avian Influenza Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Avian Influenza Vaccines by region & country, by Type, and by Application.
The Avian Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avian Influenza Vaccines.
Market Segmentation
By Company
Boehringer Ingelheim
CAHIC
DHN
HVRI
CEVA
Elanco Animal Health
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
Sindh Poultry Vaccine Centre
Merck Animal Health
PT Medion Farma Jaya
Avimex Animal Health
JOVAC
Bio-Labs
Pusvetma
IPB-Shigeta
Medion Farma Jaya
Caprifamarindo
Segment by Type
H5+H7 Avian Influenza Vaccines
H9 Avian Influenza Vaccines
Segment by Application
Chicken
Duck & Goose
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Avian Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Avian Influenza Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Avian Influenza Vaccines Product Introduction
1.2 Global Avian Influenza Vaccines Market Size Forecast
1.2.1 Global Avian Influenza Vaccines Sales Value (2020-2031)
1.2.2 Global Avian Influenza Vaccines Sales Volume (2020-2031)
1.2.3 Global Avian Influenza Vaccines Sales Price (2020-2031)
1.3 Avian Influenza Vaccines Market Trends & Drivers
1.3.1 Avian Influenza Vaccines Industry Trends
1.3.2 Avian Influenza Vaccines Market Drivers & Opportunity
1.3.3 Avian Influenza Vaccines Market Challenges
1.3.4 Avian Influenza Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Avian Influenza Vaccines Players Revenue Ranking (2024)
2.2 Global Avian Influenza Vaccines Revenue by Company (2020-2025)
2.3 Global Avian Influenza Vaccines Players Sales Volume Ranking (2024)
2.4 Global Avian Influenza Vaccines Sales Volume by Company Players (2020-2025)
2.5 Global Avian Influenza Vaccines Average Price by Company (2020-2025)
2.6 Key Manufacturers Avian Influenza Vaccines Manufacturing Base and Headquarters
2.7 Key Manufacturers Avian Influenza Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Avian Influenza Vaccines
2.9 Avian Influenza Vaccines Market Competitive Analysis
2.9.1 Avian Influenza Vaccines Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Avian Influenza Vaccines Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 H5+H7 Avian Influenza Vaccines
3.1.2 H9 Avian Influenza Vaccines
3.2 Global Avian Influenza Vaccines Sales Value by Type
3.2.1 Global Avian Influenza Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Avian Influenza Vaccines Sales Value, by Type (2020-2031)
3.2.3 Global Avian Influenza Vaccines Sales Value, by Type (%) (2020-2031)
3.3 Global Avian Influenza Vaccines Sales Volume by Type
3.3.1 Global Avian Influenza Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Avian Influenza Vaccines Sales Volume, by Type (2020-2031)
3.3.3 Global Avian Influenza Vaccines Sales Volume, by Type (%) (2020-2031)
3.4 Global Avian Influenza Vaccines Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Chicken
4.1.2 Duck & Goose
4.1.3 Other
4.2 Global Avian Influenza Vaccines Sales Value by Application
4.2.1 Global Avian Influenza Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Avian Influenza Vaccines Sales Value, by Application (2020-2031)
4.2.3 Global Avian Influenza Vaccines Sales Value, by Application (%) (2020-2031)
4.3 Global Avian Influenza Vaccines Sales Volume by Application
4.3.1 Global Avian Influenza Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Avian Influenza Vaccines Sales Volume, by Application (2020-2031)
4.3.3 Global Avian Influenza Vaccines Sales Volume, by Application (%) (2020-2031)
4.4 Global Avian Influenza Vaccines Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Avian Influenza Vaccines Sales Value by Region
5.1.1 Global Avian Influenza Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Avian Influenza Vaccines Sales Value by Region (2020-2025)
5.1.3 Global Avian Influenza Vaccines Sales Value by Region (2026-2031)
5.1.4 Global Avian Influenza Vaccines Sales Value by Region (%), (2020-2031)
5.2 Global Avian Influenza Vaccines Sales Volume by Region
5.2.1 Global Avian Influenza Vaccines Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Avian Influenza Vaccines Sales Volume by Region (2020-2025)
5.2.3 Global Avian Influenza Vaccines Sales Volume by Region (2026-2031)
5.2.4 Global Avian Influenza Vaccines Sales Volume by Region (%), (2020-2031)
5.3 Global Avian Influenza Vaccines Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Avian Influenza Vaccines Sales Value, 2020-2031
5.4.2 North America Avian Influenza Vaccines Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Avian Influenza Vaccines Sales Value, 2020-2031
5.5.2 Europe Avian Influenza Vaccines Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Avian Influenza Vaccines Sales Value, 2020-2031
5.6.2 Asia Pacific Avian Influenza Vaccines Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Avian Influenza Vaccines Sales Value, 2020-2031
5.7.2 South America Avian Influenza Vaccines Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Avian Influenza Vaccines Sales Value, 2020-2031
5.8.2 Middle East & Africa Avian Influenza Vaccines Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Avian Influenza Vaccines Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Avian Influenza Vaccines Sales Value
6.2.1 Key Countries/Regions Avian Influenza Vaccines Sales Value, 2020-2031
6.2.2 Key Countries/Regions Avian Influenza Vaccines Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Avian Influenza Vaccines Sales Value, 2020-2031
6.3.2 United States Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Avian Influenza Vaccines Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Avian Influenza Vaccines Sales Value, 2020-2031
6.4.2 Europe Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Avian Influenza Vaccines Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Avian Influenza Vaccines Sales Value, 2020-2031
6.5.2 China Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
6.5.3 China Avian Influenza Vaccines Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Avian Influenza Vaccines Sales Value, 2020-2031
6.6.2 Japan Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Avian Influenza Vaccines Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Avian Influenza Vaccines Sales Value, 2020-2031
6.7.2 South Korea Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Avian Influenza Vaccines Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Avian Influenza Vaccines Sales Value, 2020-2031
6.8.2 Southeast Asia Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Avian Influenza Vaccines Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Avian Influenza Vaccines Sales Value, 2020-2031
6.9.2 India Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
6.9.3 India Avian Influenza Vaccines Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Company Information
7.1.2 Boehringer Ingelheim Introduction and Business Overview
7.1.3 Boehringer Ingelheim Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Boehringer Ingelheim Avian Influenza Vaccines Product Offerings
7.1.5 Boehringer Ingelheim Recent Development
7.2 CAHIC
7.2.1 CAHIC Company Information
7.2.2 CAHIC Introduction and Business Overview
7.2.3 CAHIC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 CAHIC Avian Influenza Vaccines Product Offerings
7.2.5 CAHIC Recent Development
7.3 DHN
7.3.1 DHN Company Information
7.3.2 DHN Introduction and Business Overview
7.3.3 DHN Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 DHN Avian Influenza Vaccines Product Offerings
7.3.5 DHN Recent Development
7.4 HVRI
7.4.1 HVRI Company Information
7.4.2 HVRI Introduction and Business Overview
7.4.3 HVRI Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 HVRI Avian Influenza Vaccines Product Offerings
7.4.5 HVRI Recent Development
7.5 CEVA
7.5.1 CEVA Company Information
7.5.2 CEVA Introduction and Business Overview
7.5.3 CEVA Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 CEVA Avian Influenza Vaccines Product Offerings
7.5.5 CEVA Recent Development
7.6 Elanco Animal Health
7.6.1 Elanco Animal Health Company Information
7.6.2 Elanco Animal Health Introduction and Business Overview
7.6.3 Elanco Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Elanco Animal Health Avian Influenza Vaccines Product Offerings
7.6.5 Elanco Animal Health Recent Development
7.7 Zoetis
7.7.1 Zoetis Company Information
7.7.2 Zoetis Introduction and Business Overview
7.7.3 Zoetis Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Zoetis Avian Influenza Vaccines Product Offerings
7.7.5 Zoetis Recent Development
7.8 FATRO
7.8.1 FATRO Company Information
7.8.2 FATRO Introduction and Business Overview
7.8.3 FATRO Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 FATRO Avian Influenza Vaccines Product Offerings
7.8.5 FATRO Recent Development
7.9 Kyoto Biken
7.9.1 Kyoto Biken Company Information
7.9.2 Kyoto Biken Introduction and Business Overview
7.9.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Kyoto Biken Avian Influenza Vaccines Product Offerings
7.9.5 Kyoto Biken Recent Development
7.10 CAVAC
7.10.1 CAVAC Company Information
7.10.2 CAVAC Introduction and Business Overview
7.10.3 CAVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 CAVAC Avian Influenza Vaccines Product Offerings
7.10.5 CAVAC Recent Development
7.11 Ringpu Biology
7.11.1 Ringpu Biology Company Information
7.11.2 Ringpu Biology Introduction and Business Overview
7.11.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Ringpu Biology Avian Influenza Vaccines Product Offerings
7.11.5 Ringpu Biology Recent Development
7.12 Vaksindo
7.12.1 Vaksindo Company Information
7.12.2 Vaksindo Introduction and Business Overview
7.12.3 Vaksindo Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Vaksindo Avian Influenza Vaccines Product Offerings
7.12.5 Vaksindo Recent Development
7.13 Sindh Poultry Vaccine Centre
7.13.1 Sindh Poultry Vaccine Centre Company Information
7.13.2 Sindh Poultry Vaccine Centre Introduction and Business Overview
7.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Offerings
7.13.5 Sindh Poultry Vaccine Centre Recent Development
7.14 Merck Animal Health
7.14.1 Merck Animal Health Company Information
7.14.2 Merck Animal Health Introduction and Business Overview
7.14.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Merck Animal Health Avian Influenza Vaccines Product Offerings
7.14.5 Merck Animal Health Recent Development
7.15 PT Medion Farma Jaya
7.15.1 PT Medion Farma Jaya Company Information
7.15.2 PT Medion Farma Jaya Introduction and Business Overview
7.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 PT Medion Farma Jaya Avian Influenza Vaccines Product Offerings
7.15.5 PT Medion Farma Jaya Recent Development
7.16 Avimex Animal Health
7.16.1 Avimex Animal Health Company Information
7.16.2 Avimex Animal Health Introduction and Business Overview
7.16.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Avimex Animal Health Avian Influenza Vaccines Product Offerings
7.16.5 Avimex Animal Health Recent Development
7.17 JOVAC
7.17.1 JOVAC Company Information
7.17.2 JOVAC Introduction and Business Overview
7.17.3 JOVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 JOVAC Avian Influenza Vaccines Product Offerings
7.17.5 JOVAC Recent Development
7.18 Bio-Labs
7.18.1 Bio-Labs Company Information
7.18.2 Bio-Labs Introduction and Business Overview
7.18.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Bio-Labs Avian Influenza Vaccines Product Offerings
7.18.5 Bio-Labs Recent Development
7.19 Pusvetma
7.19.1 Pusvetma Company Information
7.19.2 Pusvetma Introduction and Business Overview
7.19.3 Pusvetma Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Pusvetma Avian Influenza Vaccines Product Offerings
7.19.5 Pusvetma Recent Development
7.20 IPB-Shigeta
7.20.1 IPB-Shigeta Company Information
7.20.2 IPB-Shigeta Introduction and Business Overview
7.20.3 IPB-Shigeta Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 IPB-Shigeta Avian Influenza Vaccines Product Offerings
7.20.5 IPB-Shigeta Recent Development
7.21 Medion Farma Jaya
7.21.1 Medion Farma Jaya Company Information
7.21.2 Medion Farma Jaya Introduction and Business Overview
7.21.3 Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Medion Farma Jaya Avian Influenza Vaccines Product Offerings
7.21.5 Medion Farma Jaya Recent Development
7.22 Caprifamarindo
7.22.1 Caprifamarindo Company Information
7.22.2 Caprifamarindo Introduction and Business Overview
7.22.3 Caprifamarindo Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 Caprifamarindo Avian Influenza Vaccines Product Offerings
7.22.5 Caprifamarindo Recent Development
8 Industry Chain Analysis
8.1 Avian Influenza Vaccines Industrial Chain
8.2 Avian Influenza Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Avian Influenza Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Avian Influenza Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Avian Influenza Vaccines Market Trends
Table 2. Avian Influenza Vaccines Market Drivers & Opportunity
Table 3. Avian Influenza Vaccines Market Challenges
Table 4. Avian Influenza Vaccines Market Restraints
Table 5. Global Avian Influenza Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Avian Influenza Vaccines Revenue Market Share by Company (2020-2025)
Table 7. Global Avian Influenza Vaccines Sales Volume by Company (2020-2025) & (M Doses)
Table 8. Global Avian Influenza Vaccines Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Avian Influenza Vaccines Price by Company (2020-2025) & (USD/K Doses)
Table 10. Key Manufacturers Avian Influenza Vaccines Manufacturing Base and Headquarters
Table 11. Key Manufacturers Avian Influenza Vaccines Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Avian Influenza Vaccines
Table 13. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Avian Influenza Vaccines Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Avian Influenza Vaccines Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Avian Influenza Vaccines Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Avian Influenza Vaccines Sales Market Share in Value by Type (2020-2025)
Table 20. Global Avian Influenza Vaccines Sales Market Share in Value by Type (2026-2031)
Table 21. Global Avian Influenza Vaccines Sales Volume by Type: 2020 VS 2024 VS 2031 (M Doses)
Table 22. Global Avian Influenza Vaccines Sales Volume by Type (2020-2025) & (M Doses)
Table 23. Global Avian Influenza Vaccines Sales Volume by Type (2026-2031) & (M Doses)
Table 24. Global Avian Influenza Vaccines Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Avian Influenza Vaccines Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Avian Influenza Vaccines Price by Type (2020-2025) & (USD/K Doses)
Table 27. Global Avian Influenza Vaccines Price by Type (2026-2031) & (USD/K Doses)
Table 28. Global Avian Influenza Vaccines Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Avian Influenza Vaccines Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Avian Influenza Vaccines Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Avian Influenza Vaccines Sales Market Share in Value by Application (2020-2025)
Table 32. Global Avian Influenza Vaccines Sales Market Share in Value by Application (2026-2031)
Table 33. Global Avian Influenza Vaccines Sales Volume by Application: 2020 VS 2024 VS 2031 (M Doses)
Table 34. Global Avian Influenza Vaccines Sales Volume by Application (2020-2025) & (M Doses)
Table 35. Global Avian Influenza Vaccines Sales Volume by Application (2026-2031) & (M Doses)
Table 36. Global Avian Influenza Vaccines Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Avian Influenza Vaccines Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Avian Influenza Vaccines Price by Application (2020-2025) & (USD/K Doses)
Table 39. Global Avian Influenza Vaccines Price by Application (2026-2031) & (USD/K Doses)
Table 40. Global Avian Influenza Vaccines Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Avian Influenza Vaccines Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Avian Influenza Vaccines Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Avian Influenza Vaccines Sales Value by Region (2020-2025) & (%)
Table 44. Global Avian Influenza Vaccines Sales Value by Region (2026-2031) & (%)
Table 45. Global Avian Influenza Vaccines Sales Volume by Region (M Doses): 2020 VS 2024 VS 2031
Table 46. Global Avian Influenza Vaccines Sales Volume by Region (2020-2025) & (M Doses)
Table 47. Global Avian Influenza Vaccines Sales Volume by Region (2026-2031) & (M Doses)
Table 48. Global Avian Influenza Vaccines Sales Volume by Region (2020-2025) & (%)
Table 49. Global Avian Influenza Vaccines Sales Volume by Region (2026-2031) & (%)
Table 50. Global Avian Influenza Vaccines Average Price by Region (2020-2025) & (USD/K Doses)
Table 51. Global Avian Influenza Vaccines Average Price by Region (2026-2031) & (USD/K Doses)
Table 52. Key Countries/Regions Avian Influenza Vaccines Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Avian Influenza Vaccines Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Avian Influenza Vaccines Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Avian Influenza Vaccines Sales Volume, (2020-2025) & (M Doses)
Table 56. Key Countries/Regions Avian Influenza Vaccines Sales Volume, (2026-2031) & (M Doses)
Table 57. Boehringer Ingelheim Company Information
Table 58. Boehringer Ingelheim Introduction and Business Overview
Table 59. Boehringer Ingelheim Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 60. Boehringer Ingelheim Avian Influenza Vaccines Product Offerings
Table 61. Boehringer Ingelheim Recent Development
Table 62. CAHIC Company Information
Table 63. CAHIC Introduction and Business Overview
Table 64. CAHIC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 65. CAHIC Avian Influenza Vaccines Product Offerings
Table 66. CAHIC Recent Development
Table 67. DHN Company Information
Table 68. DHN Introduction and Business Overview
Table 69. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 70. DHN Avian Influenza Vaccines Product Offerings
Table 71. DHN Recent Development
Table 72. HVRI Company Information
Table 73. HVRI Introduction and Business Overview
Table 74. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 75. HVRI Avian Influenza Vaccines Product Offerings
Table 76. HVRI Recent Development
Table 77. CEVA Company Information
Table 78. CEVA Introduction and Business Overview
Table 79. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. CEVA Avian Influenza Vaccines Product Offerings
Table 81. CEVA Recent Development
Table 82. Elanco Animal Health Company Information
Table 83. Elanco Animal Health Introduction and Business Overview
Table 84. Elanco Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 85. Elanco Animal Health Avian Influenza Vaccines Product Offerings
Table 86. Elanco Animal Health Recent Development
Table 87. Zoetis Company Information
Table 88. Zoetis Introduction and Business Overview
Table 89. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 90. Zoetis Avian Influenza Vaccines Product Offerings
Table 91. Zoetis Recent Development
Table 92. FATRO Company Information
Table 93. FATRO Introduction and Business Overview
Table 94. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 95. FATRO Avian Influenza Vaccines Product Offerings
Table 96. FATRO Recent Development
Table 97. Kyoto Biken Company Information
Table 98. Kyoto Biken Introduction and Business Overview
Table 99. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 100. Kyoto Biken Avian Influenza Vaccines Product Offerings
Table 101. Kyoto Biken Recent Development
Table 102. CAVAC Company Information
Table 103. CAVAC Introduction and Business Overview
Table 104. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 105. CAVAC Avian Influenza Vaccines Product Offerings
Table 106. CAVAC Recent Development
Table 107. Ringpu Biology Company Information
Table 108. Ringpu Biology Introduction and Business Overview
Table 109. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 110. Ringpu Biology Avian Influenza Vaccines Product Offerings
Table 111. Ringpu Biology Recent Development
Table 112. Vaksindo Company Information
Table 113. Vaksindo Introduction and Business Overview
Table 114. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 115. Vaksindo Avian Influenza Vaccines Product Offerings
Table 116. Vaksindo Recent Development
Table 117. Sindh Poultry Vaccine Centre Company Information
Table 118. Sindh Poultry Vaccine Centre Introduction and Business Overview
Table 119. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Offerings
Table 121. Sindh Poultry Vaccine Centre Recent Development
Table 122. Merck Animal Health Company Information
Table 123. Merck Animal Health Introduction and Business Overview
Table 124. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 125. Merck Animal Health Avian Influenza Vaccines Product Offerings
Table 126. Merck Animal Health Recent Development
Table 127. PT Medion Farma Jaya Company Information
Table 128. PT Medion Farma Jaya Introduction and Business Overview
Table 129. PT Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 130. PT Medion Farma Jaya Avian Influenza Vaccines Product Offerings
Table 131. PT Medion Farma Jaya Recent Development
Table 132. Avimex Animal Health Company Information
Table 133. Avimex Animal Health Introduction and Business Overview
Table 134. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 135. Avimex Animal Health Avian Influenza Vaccines Product Offerings
Table 136. Avimex Animal Health Recent Development
Table 137. JOVAC Company Information
Table 138. JOVAC Introduction and Business Overview
Table 139. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 140. JOVAC Avian Influenza Vaccines Product Offerings
Table 141. JOVAC Recent Development
Table 142. Bio-Labs Company Information
Table 143. Bio-Labs Introduction and Business Overview
Table 144. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 145. Bio-Labs Avian Influenza Vaccines Product Offerings
Table 146. Bio-Labs Recent Development
Table 147. Pusvetma Company Information
Table 148. Pusvetma Introduction and Business Overview
Table 149. Pusvetma Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 150. Pusvetma Avian Influenza Vaccines Product Offerings
Table 151. Pusvetma Recent Development
Table 152. IPB-Shigeta Company Information
Table 153. IPB-Shigeta Introduction and Business Overview
Table 154. IPB-Shigeta Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 155. IPB-Shigeta Avian Influenza Vaccines Product Offerings
Table 156. IPB-Shigeta Recent Development
Table 157. Medion Farma Jaya Company Information
Table 158. Medion Farma Jaya Introduction and Business Overview
Table 159. Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 160. Medion Farma Jaya Avian Influenza Vaccines Product Offerings
Table 161. Medion Farma Jaya Recent Development
Table 162. Caprifamarindo Company Information
Table 163. Caprifamarindo Introduction and Business Overview
Table 164. Caprifamarindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 165. Caprifamarindo Avian Influenza Vaccines Product Offerings
Table 166. Caprifamarindo Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Avian Influenza Vaccines Downstream Customers
Table 170. Avian Influenza Vaccines Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Avian Influenza Vaccines Product Picture
Figure 2. Global Avian Influenza Vaccines Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Avian Influenza Vaccines Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Avian Influenza Vaccines Sales Volume (2020-2031) & (M Doses)
Figure 5. Global Avian Influenza Vaccines Sales Price (2020-2031) & (USD/K Doses)
Figure 6. Avian Influenza Vaccines Report Years Considered
Figure 7. Global Avian Influenza Vaccines Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Avian Influenza Vaccines Players Sales Volume Ranking (2024) & (M Doses)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Avian Influenza Vaccines Revenue in 2024
Figure 10. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. H5+H7 Avian Influenza Vaccines Picture
Figure 12. H9 Avian Influenza Vaccines Picture
Figure 13. Global Avian Influenza Vaccines Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Avian Influenza Vaccines Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Avian Influenza Vaccines Sales Volume by Type (2020 VS 2024 VS 2031) & (M Doses)
Figure 16. Global Avian Influenza Vaccines Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Avian Influenza Vaccines Price by Type (2020-2031) & (USD/K Doses)
Figure 18. Product Picture of Chicken
Figure 19. Product Picture of Duck & Goose
Figure 20. Product Picture of Other
Figure 21. Global Avian Influenza Vaccines Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Avian Influenza Vaccines Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Avian Influenza Vaccines Sales Volume by Application (2020 VS 2024 VS 2031) & (M Doses)
Figure 24. Global Avian Influenza Vaccines Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Avian Influenza Vaccines Price by Application (2020-2031) & (USD/K Doses)
Figure 26. North America Avian Influenza Vaccines Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Avian Influenza Vaccines Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Avian Influenza Vaccines Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Avian Influenza Vaccines Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Avian Influenza Vaccines Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Avian Influenza Vaccines Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Avian Influenza Vaccines Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Avian Influenza Vaccines Sales Volume (%), (2020-2031)
Figure 38. United States Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Avian Influenza Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Avian Influenza Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 44. China Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 46. China Avian Influenza Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Avian Influenza Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Avian Influenza Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Avian Influenza Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 56. India Avian Influenza Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Avian Influenza Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 58. India Avian Influenza Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 59. Avian Influenza Vaccines Industrial Chain
Figure 60. Avian Influenza Vaccines Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
